|
Market Closed -
Nasdaq
04:00:00 2026-02-13 pm EST
|
5-day change
|
1st Jan Change
|
|
485.84 USD
|
+1.51%
|
 |
-0.47%
|
-14.22%
|
|
Feb. 11 |
Intuitive Surgical Insider Sold Shares Worth $260,316, According to a Recent SEC Filing
|
MT
| |
Feb. 10 |
Retail Hits the Brakes
|  | |
Feb. 04 |
Argus Adjusts Price Target on Intuitive Surgical to $560 From $630, Maintains Buy Rating
|
MT
| |
Feb. 03 |
Intuitive Surgical : Annual Report for Fiscal Year Ending 12/31, 2025 (Form 10-K)
|
PU
| |
Feb. 03 |
Tranche Update on Intuitive Surgical, Inc.'s Equity Buyback Plan announced on February 2, 2015.
|
CI
| |
Feb. 02 |
Synektik expands and extends distribution agreement with Intuitive Surgical
|
RE
| |
Jan. 27 |
Markets Are Calm. Everything Else Isn't.
| | |
Jan. 27 |
TD Cowen Initiates Coverage on Intuitive Surgical With Buy Rating, $660 Price Target
|
MT
| |
Jan. 27 |
Analyst recommendations: Doordash, Micron, PayPal, Roblox, SanDisk…
| | |
Jan. 26 |
Intuitive Announces U.S. Food and Drug Administration Cleared the Da Vinci 5 System for Certain Cardiac Procedures
|
CI
| |
Jan. 26 |
Intuitive Surgical Says FDA Approved Da Vinci 5 for Certain Cardiac Procedures
|
MT
| |
Jan. 26 |
Da Vinci 5 Cleared for Cardiac Procedures
|
GL
| |
Jan. 26 |
HSBC Adjusts Price Target on Intuitive Surgical to $653 From $644, Maintains Buy Rating
|
MT
| |
Jan. 26 |
Earnings calendar for January 26 to 30, 2026: Microsoft, Apple, LVMH and ASML ahead
| | |
Jan. 23 |
Sector Update: Health Care Stocks Softer in Afternoon Trading
|
MT
| |
Jan. 23 |
China Merchants Initiates Intuitive Surgical at Buy With $613 Price Target
|
MT
| |
Jan. 23 |
20 Million Patients Benefit from da Vinci Surgery Globally
|
GL
| |
Jan. 23 |
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Friday as Traders Look Ahead to Economic Data Releases
|
MT
| |
Jan. 23 |
The Market's Favorite Question Right Now: Is This a Return to Normal, or Just a Pause?
| | |
Jan. 23 |
Piper Sandler Adjusts Price Target on Intuitive Surgical to $620 From $610, Maintains Overweight Rating
|
MT
| |
Jan. 23 |
Evercore ISI Adjusts Price Target on Intuitive Surgical to $550 From $580, Maintains In Line Rating
|
MT
| |
Jan. 23 |
Bernstein Adjusts Price Target on Intuitive Surgical to $750 From $740, Maintains Outperform Rating
|
MT
| |
Jan. 23 |
Baird Adjusts Price Target on Intuitive Surgical to $645 From $655, Maintains Outperform Rating
|
MT
| |
Jan. 23 |
Raymond James Adjusts Price Target on Intuitive Surgical to $615 From $603, Maintains Outperform Rating
|
MT
| |
Jan. 23 |
Leerink Partners Adjusts Price Target on Intuitive Surgical to $622 From $600, Maintains Outperform Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
